ProShare Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-466,312
| Closed | -$85.7M | – | 1882 |
|
|
2025
Q4 | $85.7M | Buy |
466,312
+138,882
| +42% | +$24.4M | 0.15% | 145 |
|
|
2025
Q3 | $50.2M | Sell |
327,430
-89,401
| -21% | -$13.5M | 0.11% | 162 |
|
|
2025
Q2 | $58.3M | Buy |
416,831
+24,128
| +6% | +$3.38M | 0.12% | 162 |
|
|
2025
Q1 | $57.7M | Buy |
392,703
+48,612
| +14% | +$7.03M | 0.13% | 153 |
|
|
2024
Q4 | $45.1M | Buy |
344,091
+53,861
| +19% | +$7.54M | 0.1% | 166 |
|
|
2024
Q3 | $45.2M | Buy |
290,230
+25,441
| +10% | +$4.11M | 0.11% | 154 |
|
|
2024
Q2 | $41.3M | Sell |
264,789
-39,598
| -13% | -$5.96M | 0.11% | 150 |
|
|
2024
Q1 | $41.2M | Buy |
304,387
+60,714
| +25% | +$8.04M | 0.11% | 160 |
|
|
2023
Q4 | $32.8M | Sell |
243,673
-44,862
| -16% | -$5.83M | 0.1% | 194 |
|
|
2023
Q3 | $39.1M | Buy |
288,535
+39,376
| +16% | +$5.38M | 0.12% | 155 |
|
|
2023
Q2 | $35.7M | Sell |
249,159
-22,840
| -8% | -$3.36M | 0.1% | 173 |
|
|
2023
Q1 | $37.8M | Buy |
271,999
+16,275
| +6% | +$2.19M | 0.12% | 161 |
|
|
2022
Q4 | $34.7M | Sell |
255,724
-29,399
| -10% | -$3.69M | 0.12% | 171 |
|
|
2022
Q3 | $31.3M | Sell |
285,123
-47,580
| -14% | -$6.04M | 0.12% | 147 |
|
|
2022
Q2 | $44M | Sell |
332,703
-152,968
| -31% | -$20.1M | 0.15% | 135 |
|
|
2022
Q1 | $64.4M | Buy |
485,671
+442,974
| +1,037% | +$53.1M | 0.14% | 151 |
|
|
2021
Q4 | $4.97M | Buy |
42,697
+9,336
| +28% | +$1.1M | 0.01% | 569 |
|
|
2021
Q3 | $4.01M | Buy |
33,361
+1,315
| +4% | +$153K | 0.01% | 551 |
|
|
2021
Q2 | $3.84M | Buy |
32,046
+251
| +0.8% | +$27.5K | 0.01% | 552 |
|
|
2021
Q1 | $3.16M | Sell |
31,795
-5,948
| -16% | -$598K | 0.01% | 563 |
|
|
2020
Q4 | $3.77M | Buy |
+37,743
| New | +$4M | 0.01% | 489 |
|
Other funds holding AZN
IA
VCM
VAM